HYDERABAD, India, and MISSISSAUGA, Ontario, April 1, 2011 /PRNewswire/ -- Promius Pharma, LLC, an affiliate of Dr. Reddy's Laboratories (NYSE:RDY), and Valeant Pharmaceuticals International, Inc.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Dr. Reddy’s Laboratories’ wholly owned U.S. subsidiary Promius Pharma has sold rights of Cloderm (clocortolone pivalate) cream and its authorised generic to EPI Health. Under the agreement, Promius ...
Promius Pharma LLC, an arm of Dr Reddy's Laboratories, today said it has bought the USA marketing rights of Cloderm (clocortolone pivalate 0.1%) cream manufactured by Canada-based Valeant ...
Dr Reddy’s Laboratories on Tuesday said its subsidiary Promius Pharma sold rights of specialty skin cream Cloderm and its authorised generic to EPI Health. "Under the terms of the agreement, Promius ...
"Promius Pharma, LLC, has sold its rights of Cloderm (clocortolone pivalate) cream, 0.1 per cent and its authorised generic to EPI Health, LLC, an affiliate of EPI Group, LLC," DRL said in a statement ...
https://www.thehindubusinessline.com/companies/dr-reddys-sells-cloderm-cream-franchise-to-epi-health/article25103232.ece Copy Dr Reddy’s Laboratories Ltd, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results